BioSpace News Archive

Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced the publication of the second interim analysis of the open-label Phase 1 study of mRNA-1273, its vaccine candidate against COVID-19, in The New England Journal of Medicine.

Integrated DNA Technologies (IDT), a leading comprehensive genomics solutions provider, announced that it has established an official business entity in China with the launch of IDT China

Pfizer to invest $200 million in CStone shares and license CStone’s late-stage oncology asset sugemalimab (CS1001, PD-L1 antibody) in mainland China

Challenged by Similar Clinical Presentations, Accurate Detection & Differentiation of all 4 Viruses is Critical for Clinicians This Flu Season

Tmunity Therapeutics, Inc., a private clinical-stage biotherapeutics company focused on saving and improving lives by delivering the full potential of next-generation T-cell immunotherapy, announced that President & CEO Usman “Oz” Azam is scheduled to present at two upcoming virtual investor conferences.

Aclipse Therapeutics was awarded a US$720,000 drug development grant from FightMND for the development of M102, a targeted therapy for Amyotrophic Lateral Sclerosis

AngioDynamics, Inc., a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, announced financial results for the first quarter of fiscal year 2021, which ended August 31, 2020.

Dr. Leider, chief medical officer at Gelesis and formerly Walgreens, brings strong medical background and experience in clinical development to the board

Organicell Regenerative Medicine, Inc. (OTCBB: BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, announced that the U.S. Food and Drug Administration (FDA) granted expanded access for an intermediate size population allowing its proprietary therapeutic, Zofin for the treatment of COVID-19. Thi

Multi-year deal will enhance lab services for patients and providers throughout eastern Gulf Coast region